介護の統合的腫瘍学モデル:NCCN加盟機関の実践パターン
Angela F Bazzell1, Lydia T Madsen1, Lindsey Bandini2
1From Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
Journal of the advanced practitioner in oncology
|February 16, 2026
まとめ
癌患者は統合腫瘍学 (IO) を求めるが,アクセス上の課題に直面している. 全国総合がんネットワーク (NCCN) のセンターを調査したところ,IOサービスが広く提供されているが,提供と資金調達には大きな違いがあることが明らかになった.
科学分野:
- 統合腫瘍学 統合腫瘍学
- がん治療のケアを提供している.
- 医療サービス 研究 医療サービス
背景:
- がん患者の場合,統合性腫瘍学 (IO) の実践を利用したいことが多い.
- 患者は安全で効果的なIOサービスやプロバイダーを見つけるのに苦労します.
- 全国総合がんネットワーク (NCCN) は,その加盟機関のIO実践を調査した.
研究 の 目的:
- 全国総合がんネットワーク (NCCN) 加盟機関の統合性腫瘍学 (IO) 実践に関する調査を行う.
- がんセンターが患者さんにIOサービスをどのように提供するかを理解する.
- IOサービス提供におけるバリエーションと潜在的なベストプラクティスを特定する.
主な方法:
- ウェブベースの調査は,NCCNの加盟機関の代表者に配布されました.
- 調査結果をまとめるために記述的統計が使用されました.
- 調査は,提供されているIOサービスの種類と患者のアクセス方法に焦点を当てました.
主要な成果:
- 調査対象となった29のNCCNセンターはすべて,栄養,ストレス管理,マインド・ボディ・プラクティス,理学療法,治療,マッサージなどのIOサービスを提供しています.
- 患者のアクセスは主に提供者の紹介を通じて発生し,いくつかの自己スケジューリングオプションがあります.
- IOサービスの資金調達モデル (自己報酬,保険,慈善事業) と紹介アルゴリズムには大きな違いがあります.
結論:
- NCCNの加盟機関の統合性腫瘍学 (IO) サービスの提供方法には大きな違いがあります.
- 研究結果は,IOサービスを開発する医療機関に対するガイドラインを提供し,ベストプラクティスを調整するための分野を強調しています.
- 非学術的な環境では挑戦的ですが,このデータは,がん患者の一般的に求められているIOサービスについて,がんのプロバイダーに情報を与えます.
関連する概念動画
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...